Health
Trailing the First Vaccines, Next Generation Turns to Variants – BloombergQuint
Trailing the First Vaccines, Next Generation Turns to Variants
(Bloomberg) — The rapid rollout of vaccines from front-runners including Pfizer Inc. is forcing those trailing behind to shift their focus to fighting potentially more dangerous versions of the coronavirus and find other ways to deploy their technologies.
Imperial College London is unlikely to go ahead with a late-stage trial in the U.K. to test its experimental Covid-19 shot, now that three vaccines have been approved in the country, according to Robin Shattock, the professor leading the research….
-
Noosa News23 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Business21 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General23 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers
-
Business22 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?